| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 287.47▲ | 287.71▲ | 288.04▼ | 302.25▼ | 295.75▼ |
| MA10 | 287.63▲ | 287.80▼ | 293.27▼ | 302.91▼ | 285.12▲ |
| MA20 | 287.88▼ | 294.17▼ | 300.10▼ | 295.59▼ | 283.47▲ |
| MA50 | 287.94▼ | 302.22▼ | 303.69▼ | 280.56▲ | 303.30▼ |
| MA100 | 292.92▼ | 303.61▼ | 300.31▼ | 288.50▼ | 294.60▼ |
| MA200 | 299.99▼ | 299.13▼ | 289.88▼ | 306.04▼ | 308.15▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.020▼ | -0.132▼ | -1.790▼ | -1.013▼ | 3.153▲ |
| RSI | 46.849▼ | 29.857▼ | 22.071▼ | 44.238▼ | 47.983▼ |
| STOCH | 27.716 | 41.469 | 19.329▼ | 65.337 | 85.760▲ |
| WILL %R | -65.854 | -80.488▼ | -81.365▼ | -83.980▼ | -37.506 |
| CCI | -28.119 | -41.441 | -68.533 | -169.425▼ | 55.023 |
| RSI | $BIIB RSI(14) Crossed Below 50 | Set Alert |
| ▼ MACD | $BIIB MACD(12,26,9) Crossed Below Signal Line | Set Alert |
| MA | $BIIB Price Crossed Below MA(26) | Set Alert |
| MA | $BIIB Price Crossed Below MA(13) | Set Alert |
| ▼ GAP | $BIIB Open Gap Down %3 | Set Alert |
| ▼ GAP | $BIIB Open Gap Down %2 | Set Alert |
| ▼ BREAK | $BIIB Price Breaks 10 Days Low | Set Alert |
|
Monday, June 18, 2018 11:32 AM
Likewise, Biogen (NASDAQ: BIIB) and Ionis Pharmaceuticals (NASDAQ: IONS), which have the only SMA drug on the market, are feeling the heat from the promising data with shares down 5.6% and 7.3%, respectively. Image source: Getty Images. The 182-day update ...
|
|
Monday, June 18, 2018 09:55 AM
PTC Therapeutics (NASDAQ:PTCT) is up 36% premarket on light volume on the heels of its announcement of positive results from its open-label FIREFISH study evaluating risdiplam (RG7916) in babies with Type 1 spinal muscular atrophy (SMA). The data were ...
|
|
Friday, June 15, 2018 09:08 AM
As far as additional individual names, I also like Regeneron (NASDAQ:REGN), Biogen (NASDAQ:BIIB), Celgene (NASDAQ:CELG), and Vertex Pharmaceuticals (NASDAQ:VRTX), among others for the long haul. I stick to everything I have written on gold in the last few ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 18/06/18 | 292.61 | 294.195 | 283.365 | 287.76 | 2,741,704 |
| 15/06/18 | 304.90 | 309.25 | 304.075 | 304.84 | 1,762,294 |
| 14/06/18 | 305.27 | 309.51 | 304.82 | 305.50 | 1,075,885 |
| 13/06/18 | 305.585 | 310.80 | 305.585 | 307.15 | 959,412 |
| 12/06/18 | 306.345 | 308.00 | 304.27 | 306.02 | 934,976 |
| 11/06/18 | 303.65 | 308.87 | 303.22 | 307.07 | 1,041,459 |
| 08/06/18 | 304.04 | 304.57 | 300.415 | 303.10 | 1,289,470 |
| 07/06/18 | 304.04 | 307.255 | 303.23 | 305.74 | 1,131,052 |
| 06/06/18 | 299.98 | 303.84 | 299.01 | 303.29 | 991,448 |
| 05/06/18 | 299.315 | 301.60 | 296.10 | 298.61 | 781,705 |
|
|
||||
|
|
||||
|
|
||||
|
|